Inflammation is a critical component of the immune response that plays a pivotal role in maintaining tissue homeostasis.

Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related mortality globally. The advent of immunotherapy, particularly immune checkpoint ...

Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. Genmab and BioNTech SE are ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

Genelux Corp. (($GNLX)) announced an update on their ongoing clinical study. Genelux Corp. is currently conducting a Phase 2 clinical study titled ...

MAIA also announced that it has enrolled five patients from Taiwan and Turkey in the expansion phase of its THIO-101 Phase 2 trial. Screening for the trial is ongoing in Europe and Asia. With ...

Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

A study presented at the annual European Society of Medical Oncology Congress 2025 and published in the journal Annals of ...

“The results of our analysis showed that overall, patients with SCLC who survived to receive 3L treatment are a select group ...